A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma

Abstract Cardiovascular calcification (CVC) is a progressive complication of chronic kidney disease and a predictor of CV events and mortality. The use of biomarkers to predict CV risk and activities of potential or current treatment drugs in these patients could have a crucial impact on therapeutic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. D. Ferrer, M. M. Pérez, M. M. Cànaves, J. M. Buades, C. Salcedo, J. Perelló
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cadcfe53061740c5bcebca312cf6e6ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!